Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]:
SEC Accession No. 0001144204-19-040143
Filing Date
2019-08-14
Accepted
2019-08-14 17:26:49
Documents
5
Effectiveness Date
2019-08-14

Document Format Files

Seq Description Document Type Size
1 SUPPL tv527692_suppl.htm SUPPL 530938
2 GRAPHIC tv527692_img01.jpg GRAPHIC 10058
3 GRAPHIC tv527692_img02.jpg GRAPHIC 149359
4 GRAPHIC tv527692_img03.jpg GRAPHIC 140141
5 GRAPHIC tv527692_img04.jpg GRAPHIC 4169
  Complete submission text file 0001144204-19-040143.txt   950889
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SUPPL | Act: 98 | File No.: 333-224432 | Film No.: 191027727
SIC: 2834 Pharmaceutical Preparations